Primary record
BUTANOIC ACID, 2,3-DIHYDROXY-2-(1-METHYLETHYL)-, (2,3,5,7A-TETRAHYDRO-1-HYDROXY-1H-PYRROLIZIN-7-YL)METHYL ESTER, (1R-(1.ALPHA.,7(2S*,3S*),7A.BETA.))-
- 库存
- 2,509 克
- 纯度
- 98.7 %
- CAS
- 10285-07-1
化合物标识与属性
- CAS
- 10285-07-1
- PubChem CID
- 107938
- SMILES
- C[C@@H]([C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1[C@@H](CC2)O)O)O
- Canonical SMILES
- CC(C)[C@@](O)(C(=O)OCC1=CCN2CC[C@@H](O)[C@@H]12)[C@H](C)O
名称与同义词
- Lycopsamine
- Intermedine
- (+)-Lycopsamine
- retinylpalmitat
- Echinatine
- 10285-07-1
- (+)-Intermedine
- UER4ET3OHI
- Lycopsamine Impurity 1
- CCIRS 9199
- RefChem:41791
- UNII-UER4ET3OHI
- 9-Viridiflorylretronecine
- Lycopsamine, HPLC Grade
- 3'-EPI-INTERMEDINE
- 3'-EPI-LYCOPSAMINE
- CCRIS 9199
- DTXSID60145542
- AC1L330T
- CHEBI:6598
- orb1696251
- DTXCID9068033
- C15H25NO5
- CTK8E0552
- MFCD09260181
- SFVVQRJOGUKCEG-ZGFBFQLVSA-N
- KST-1A0390
- MSK14171
- AR-1A8021
- C15-H25-N-O5
- CID107938
- Lycopsamine 100 microg/mL in Water
- AKOS040752803
- DA-55120
- FL161608
- J15.603E
- HY-124916
- LS-182548
- RETRONECINE 9-((-)-VIRIDIFLORATE)
- CS-0089560
- NS00098507
- C10347
- A902557
- Q27107262
- Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, ((1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, (2S,3S)-
- Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, (1R-(1alpha,7(2S*,3S*),7abeta))-
- (1R-(1alpha,7(2S*,3S*),7abeta))-(2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl 2,3-dihydroxy-2-(1-methylethyl)butanoate
- [(1R,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate
- [(1r,7ar)-1-hydroxy-2,3,5,7a-tetrahydro-1h-pyrrolizin-7-yl]methyl(2s,3s)-2,3-dihydroxy-2-(propan-2-yl)butanoate
- 10340-91-7
- ((1R,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl (2S,3S)-2,3-dihydroxy-2-isopropylbutanoate
- [(7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate
- ((7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl)methyl (2S)-2-hydroxy-2-((1S)-1-hydroxyethyl)-3-methyl-butanoate
- ((7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl)methyl (2S)-2-hydroxy-2-((1S)-1-hydroxyethyl)-3-methylbutanoate
- (2S,3S)-2,3-Dihydroxy-2-isopropylbutanoic acid [(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizine-7-yl]methyl ester
- (2S,3S)-2,3-Dihydroxy-2-isopropylbutanoic acid [(5R,6R)-6-hydroxy-1-azabicyclo[3.3.0]octa-3-ene-4-yl]methyl ester
- (2S,3S)-2,3-Dihydroxy-2-isopropylbutanoic acid [(7R)-7beta-hydroxy-5,6,7,7aalpha-tetrahydro-3H-pyrrolizine-1-yl]methyl ester
- [(1R,7aR)-1-Hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl (2S,3S)-2,3-dihydroxy-2-(propan-2-yl)butanoate
- [(7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methyl-butanoate
- 10285-06-0
- BUTANOIC ACID, 2,3-DIHYDROXY-2-(1-METHYLETHYL)-, (2,3,5,7A-TETRAHYDRO-1-HYDROXY-1H-PYRROLIZIN-7-YL)METHYL ESTER, (1R-(1.ALPHA.,7(2S*,3S*),7A.BETA.))-
- Butanoic acid,2,3-dihydroxy-2-(1-methylethyl)-,[(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester,(2S,3S)-